Methylnaltrexone Subcutaneous and Spravato (56 MG Dose)
Determining the interaction of Methylnaltrexone Subcutaneous and Spravato (56 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylnaltrexone
Brand name: Relistor
Synonyms: Methylnaltrexone (Subcutaneous), Methylnaltrexone, Methylnaltrexone (oral/injection)
Generic Name: esketamine
Brand name: Spravato
Synonyms: Spravato Nasal Spray, Spravato
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylnaltrexone Subcutaneous-Spravato (84 MG Dose)
- Methylnaltrexone Subcutaneous-Sprintec
- Methylnaltrexone Subcutaneous-Sprintec 28
- Methylnaltrexone Subcutaneous-Spritam
- Methylnaltrexone Subcutaneous-Sprix
- Methylnaltrexone Subcutaneous-Sprix Nasal Spray
- Spravato (56 MG Dose)-Methylnaltrexone Tablets
- Spravato (56 MG Dose)-Methylphen Tablets
- Spravato (56 MG Dose)-Methylphenidate
- Spravato (56 MG Dose)-Methylphenidate CD Capsules
- Spravato (56 MG Dose)-Methylphenidate Chewable Tablets
- Spravato (56 MG Dose)-Methylphenidate Controlled-Release Tablets